Results 91 to 100 of about 46,348 (289)
Role of internal limiting membrane peeling for cases of recalcitrant diabetic macular edema
Kerala Journal of Ophthalmology, 2017 Background/Aims: To investigate the efficacy of internal limiting membrane (ILM) peeling following pars plana vitrectomy for cases of recalcitrant diabetic macular edema in terms of improved visual acuity and reduced central macular thickness (CMT ...
Sujit Das, Rakesh Maggon
doaj +1 more source
Ensemble of Convolutional Neural Networks for Automatic Grading of Diabetic Retinopathy and Macular Edema [PDF]
arXiv, 2018 In this manuscript, we automate the procedure of grading of diabetic retinopathy and macular edema from fundus images using an ensemble of convolutional neural networks. The availability of limited amount of labeled data to perform supervised learning was circumvented by using transfer learning approach. The models in the ensemble were pre-trained on a
arxiv
Micro-implant d'acétonide de fluocinolone (ILUVIEN(®)) pour l'oedème maculaire diabétique chronique [Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema]. [PDF]
, 2015 Diabetic macular edema (DME) is a frequent complication of diabetic retinopathy and may cause severe visual loss. In this article, we examine the pathophysiology of DME and review various treatment options, such as laser photocoagulation, anti-vascular ...
Behar-Cohen, F., Soubrane, G.
core +1 more source
Acta Ophthalmologica, EarlyView.Abstract This review covers a seminal study of the relation between exposure to the glucagon‐like peptide 1 (GLP‐1) agonist semaglutide and incident non‐arteritic anterior ischaemic optic neuropathy (NAION) in a neuro‐ophthalmology clinic setting, subsequent studies in unselected populations, a meta‐analysis of clinical trials and pathophysiology ...
Abdullah Amini +2 more
wiley +1 more source
Indian Journal of Ophthalmology, 2017 Purpose: Triamcinolone acetonide (TA) is an alternative option for diabetic macular edema thanks to its cost-benefit ratio and unique delivery route. We performed this study to compare vitrectomized with nonvitrectomized eyes treated with subtenon TA ...
Kang Yeun Pak +4 more
doaj +1 more source
Transscleral Micropulse Diode Laser for Treatment of Diabetic Retinopathy [PDF]
arXiv, 2017 In this study, we introduced a new simple effective technique for the treatment of diabetic retinopathy by the treatment of the periphery of the retina by transscleral micropulse diode laser (Taha Technique). Macular edema was improved and vitreous hemorrhage was disappeared in most of the cases.
arxiv
Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema [PDF]
Diabetic macular edema is the major cause of visual acuity impairment in diabetic patients. The exact etiopathogenesis is unknown and, currently, grid/focal retinal laser photocoagulation represents the recommended treatment.
Bandello, Francesco +5 more
core +3 more sources
Central Macular Thickness in Diabetic Macular Edema
Acta Endocrinologica (Bucharest), 2020 Retinal microvascular dysfunction differs in macular edema lesions in the two eyes of the same patient with diabetic retinopathy.To evaluate the relationship between central macular thickness (CMT) and metabolic/systemic factors including anthropometric and laboratory findings, in patients with regressed diabetic retinopathy and a history of pars plana
Güngel, H. +4 more
openaire +3 more sources
Acta Ophthalmologica, EarlyView.Abstract Purpose To evaluate the incidence and risk factors for secondary ocular hypertension (SOHT) following intravitreal dexamethasone implants (Ozurdex®) in patients with diabetic macular oedema (DME) and macular oedema secondary to retinal vein occlusion (RVO) in a Swedish cohort.
Imadeddin Abu Ishkheidem +5 more
wiley +1 more source
Ranibizumab For Diabetic Macular Edema Refractory To Multiple Prior Treatments [PDF]
, 2016 Purpose: Diabetic macular edema can be refractory to multiple treatment modalities. Although there have been anecdotal reports of ranibizumab showing efficacy when other modalities provided limited benefit, little has been published on treatment for ...
Ciulla, Lauren +4 more
core +2 more sources